NU SKIN ENTERPRISES, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was -$59.00K.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was -$53.00K.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was -$60.00K, a 110.03% decline year-over-year.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was -$1.89M, a 145.20% decline year-over-year.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for fiscal 2024 was -$2.06M, a 145.23% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $4.56M, a 83.14% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $27.05M, a 95.17% increase from fiscal 2021.
- NU SKIN ENTERPRISES, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $13.86M, a 140.48% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$2.06M 10-K · filed 2025-02-14 |
| 2024-09-30 | -$53.00K 10-Q · filed 2024-11-08 | -$2.18M derived: sum of 4 quarters · filed 2025-02-14 |
| 2024-06-30 | -$60.00K 10-Q · filed 2024-08-09 | -$2.17M derived: sum of 4 quarters · filed 2025-02-14 |
| 2024-03-31 | -$1.89M 10-Q · filed 2024-05-09 | -$1.51M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $4.56M 10-K · filed 2025-02-14 |
| 2023-09-30 | -$41.00K 10-Q · filed 2024-11-08 | $6.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $598.00K 10-Q · filed 2024-08-09 | $7.24M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $4.18M 10-Q · filed 2024-05-09 | $27.72M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $27.05M 10-K · filed 2025-02-14 |
| 2022-09-30 | $1.20M 10-Q · filed 2023-11-02 | $31.78M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $21.08M 10-Q · filed 2023-08-02 | $32.53M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $3.52M 10-Q · filed 2023-05-04 | $17.85M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $13.86M 10-K · filed 2024-02-15 |
| 2021-09-30 | $1.95M 10-Q · filed 2022-11-03 | $10.32M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $6.41M 10-Q · filed 2022-08-05 | $9.32M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$477.00K 10-Q · filed 2022-05-05 | $6.69M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $5.76M 10-K · filed 2023-02-16 |
| 2020-09-30 | $945.00K 10-Q · filed 2021-11-04 | $3.32M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $3.78M 10-Q · filed 2021-08-05 | $2.36M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$1.41M 10-Q · filed 2021-05-05 | -$1.58M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$2.33M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$18.00K 10-Q · filed 2020-11-05 | -$544.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$152.00K 10-Q · filed 2020-08-06 | $2.52M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | -$2.16M 10-Q · filed 2020-05-07 | $8.32M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $10.78M 10-K · filed 2021-02-11 |
| 2018-09-30 | $3.04M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $5.65M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $299.00K 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $24.44M 10-K · filed 2020-02-13 | |
| 2016-12-31 | $14.31M 10-K · filed 2019-02-14 | |
| 2015-12-31 | $3.31M 10-K · filed 2018-02-16 | |
| 2014-12-31 | -$2.42M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $34.37M 10-K · filed 2016-02-18 | |
| 2012-12-31 | $4.57M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $29.71M 10-K · filed 2014-03-18 | |
| 2010-12-31 | $21.18M 10-K · filed 2013-02-27 | |
| 2009-12-31 | $6.23M 10-K · filed 2012-02-28 | |
| 2008-12-31 | $3.82M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |